Group One Trading’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-27,400
| Closed | -$1.3M | – | 8026 |
|
|
2025
Q3 | $1.3M | Sell |
27,400
-33,300
| -55% | -$1.61M | ﹤0.01% | 2754 |
|
|
2025
Q2 | $3.24M | Buy |
60,700
+54,500
| +879% | +$2.48M | 0.01% | 1688 |
|
|
2025
Q1 | $251K | Sell |
6,200
-23,800
| -79% | -$1.01M | ﹤0.01% | 3774 |
|
|
2024
Q4 | $835K | Buy |
30,000
+5,600
| +23% | +$170K | ﹤0.01% | 2737 |
|
|
2024
Q3 | $700K | Buy |
24,400
+2,300
| +10% | +$60K | ﹤0.01% | 2597 |
|
|
2024
Q2 | $518K | Sell |
22,100
-28,900
| -57% | -$618K | ﹤0.01% | 2529 |
|
|
2024
Q1 | $1.29M | Sell |
51,000
-73,600
| -59% | -$1.77M | ﹤0.01% | 1867 |
|
|
2023
Q4 | $2.91M | Buy |
124,600
+3,500
| +3% | +$69K | 0.01% | 1556 |
|
|
2023
Q3 | $6.13M | Buy |
121,100
+96,700
| +396% | +$4.5M | 0.02% | 808 |
|
|
2023
Q2 | $1.14M | Buy |
24,400
+6,100
| +33% | +$280K | ﹤0.01% | 2239 |
|
|
2023
Q1 | $700K | Sell |
18,300
-13,700
| -43% | -$611K | ﹤0.01% | 2446 |
|
|
2022
Q4 | $1.75M | Sell |
32,000
-13,100
| -29% | -$561K | ﹤0.01% | 1935 |
|
|
2022
Q3 | $1.54M | Buy |
+45,100
| New | +$690K | ﹤0.01% | 2133 |
|
|
2021
Q4 | – | Sell |
-500
| Closed | -$11K | – | 8129 |
|
|
2021
Q3 | $11K | Buy |
500
+300
| +150% | +$6.79K | ﹤0.01% | 7441 |
|
|
2021
Q2 | $5K | Sell |
200
-3,400
| -94% | -$95.5K | ﹤0.01% | 7740 |
|
|
2021
Q1 | $104K | Buy |
3,600
+3,500
| +3,500% | +$106K | ﹤0.01% | 5625 |
|
|
2020
Q4 | $3K | Buy |
+100
| New | +$2.78K | ﹤0.01% | 6143 |
|
|
2020
Q3 | – | Sell |
-8,200
| Closed | -$204K | – | 6027 |
|
|
2020
Q2 | $204K | Buy |
+8,200
| New | +$187K | ﹤0.01% | 3362 |
|
Other funds holding AKRO
Group One Trading's AKRO Position: Q4 2025 in Review
Group One Trading sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 20,381 shares — an estimated $968K sold.
Group One Trading first reported a position in AKRO in Q1 2020 and held it in 17 quarters. The position peaked at $6.83M in Q4 2022. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.
- Group One Trading reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
- Group One Trading sold 20,381 Akero Therapeutics shares in Q4 2025, an estimated $968K.
- Group One Trading first reported a position in Akero Therapeutics in Q1 2020 and held it in 17 quarters.
- Group One Trading's Akero Therapeutics position peaked at $6.83M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.
Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.